Yuhan Corporation (000105.KS), a pharmaceutical company, on Thursday reported first-quarter 2026 results with mixed performance, as revenue and operating income increased year on year, while profit before tax and net income declined.
Net income from continuing operation before income tax fell to 41.203 billion won from 43.426 billion won in the same period last year.
Operating income rose to 8.830 billion won, compared with 8.645 billion won a year earlier.
Net income declined 5% to 37.357 billion won from 39.331 billion won in the prior-year period.
Sales increased to 509.616 billion won from 469.412 billion won last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.